x
Filter:
Filters applied
- JTO: Editors Choice
- Casini, BeatriceRemove Casini, Beatrice filter
- Lung adenocarcinomaRemove Lung adenocarcinoma filter
Publication Date
Please choose a date range between 2019 and 2019.
Author
- Barba, Maddalena1
- Barchiesi, Giacomo1
- Buglioni, Simonetta1
- Ciliberto, Gennaro1
- Ciuffreda, Ludovica1
- de Maria, Ruggero1
- de Nicola, Francesca1
- Fanciulli, Maurizio1
- Gallo, Enzo1
- Goeman, Frauke1
- Krasniqi, Eriseld1
- Maugeri-Saccà, Marcello1
- Mazzotta, Marco1
- Pallocca, Matteo1
- Pescarmona, Edoardo1
- Pizzuti, Laura1
- Scalera, Stefano1
- Sperati, Francesca1
- Vici, Patrizia1
- Visca, Paolo1
Editors Choice
1 Results
- Original Article Translational OncologyOpen Archive
Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma
Journal of Thoracic OncologyVol. 14Issue 11p1924–1934Published online: July 16, 2019- Frauke Goeman
- Francesca De Nicola
- Stefano Scalera
- Francesca Sperati
- Enzo Gallo
- Ludovica Ciuffreda
- and others
Cited in Scopus: 43Molecular characterization studies revealed recurrent kelch like ECH associated protein 1 gene (KEAP1)/nuclear factor, erythroid 2 like 2 gene (NFE2L2) alterations in NSCLC. These genes encode two interacting proteins (a stress response pathway [SRP]) that mediate a cytoprotective response to oxidative stress and xenobiotics. Nevertheless, whether KEAP1/NFE2L2 mutations have an impact on clinical outcomes is unclear.